Published in Acta Pathol Microbiol Immunol Scand B on December 01, 1983
Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun (1986) 2.89
Effect of toxin A and B of Clostridium difficile on rabbit ileum and colon. Gut (1986) 1.93
Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin. Infect Immun (1987) 1.57
Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria. Appl Environ Microbiol (1985) 1.47
Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. J Clin Invest (1988) 1.41
Interaction of Clostridium difficile toxin A with cultured cells: cytoskeletal changes and nuclear polarization. Infect Immun (1990) 1.29
The enterotoxicity of Clostridium difficile toxins. Toxins (Basel) (2010) 1.07
Cloning of a genetic determinant from Clostridium difficile involved in adherence to tissue culture cells and mucus. Infect Immun (1994) 1.03
Adjusting for multiple testing--when and how? J Clin Epidemiol (2001) 8.85
Tissue receptor for cholera exotoxin: postulated structure from studies with GM1 ganglioside and related glycolipids. Infect Immun (1973) 4.08
Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med (1996) 3.41
Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology (1998) 3.00
Events per person year--a dubious concept. BMJ (1995) 2.65
Interaction of cholera toxin and toxin derivatives with lymphocytes. I. Binding properties and interference with lectin-induced cellular stimulation. J Exp Med (1974) 2.42
Development of improved cholera vaccine based on subunit toxoid. Nature (1977) 2.42
Experimental Staphylococcus aureus arthritis in mice. Infect Immun (1991) 2.24
Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet (1996) 2.20
Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. Proc Natl Acad Sci U S A (1975) 2.18
Immunochemical Studies of Two Cholera Toxin-Containing Standard Culture Filtrate Preparations of Vibrio cholerae. Infect Immun (1971) 2.17
Correlation between intestinal synthesis of specific immunoglobulin A and protection against experimental cholera in mice. Infect Immun (1978) 2.12
Fixation and inactivation of cholera toxin by GM1 ganglioside. Scand J Infect Dis (1973) 1.90
Protective antitoxic cholera immunity in mice: influence of route and number of immunizations and mode of action of protective antibodies. Acta Pathol Microbiol Scand C (1978) 1.86
Subunit structure of cholera toxin. J Gen Microbiol (1973) 1.78
Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum (1990) 1.75
Hearing screening in newborns: systematic review of accuracy, effectiveness, and effects of interventions after screening. Arch Dis Child (2009) 1.64
Antisecretory factor suppresses intestinal inflammation and hypersecretion. Gut (1997) 1.57
Establishment and characterization of chicken embryo fibroblast clone LSCC-H32. In Vitro (1982) 1.46
[Effect of colloidal plasma substitutes on liberation of tumor necrosis factor-alpha (TNF-alpha) in human whole blood in vitro]. Infusionsther Transfusionsmed (1995) 1.41
[Benefit assessment of PET in malignant lymphomas. The IQWiG point of view]. Nuklearmedizin (2010) 1.39
Comparison of the efficacy and safety of aspirin alone with coumadin plus aspirin after provisional coronary stenting: final and follow-up results of a randomized study. Am Heart J (1999) 1.39
Induction of anti-secretory factor in human milk may prevent mastitis. Acta Paediatr (2004) 1.39
Reversal of cyclic AMP-mediated intestinal secretion in mice by chlorpromazine. Gastroenterology (1978) 1.32
Protein reagent modification of cholera toxin: characterization of effects on antigenic, receptor-binding and toxic properties. J Gen Microbiol (1975) 1.32
Fetal heart rate variability and complexity in the course of pregnancy. Early Hum Dev (1999) 1.30
Local cholera immunity in mice: intestinal antitoxin-containing cells and their correlation with protective immunity. Infect Immun (1979) 1.20
Multiple test procedures other than Bonferroni's deserve wider use. BMJ (1999) 1.17
Enterotoxins from Clostridium difficile; diarrhoeogenic potency and morphological effects in the rat intestine. Gut (1990) 1.15
Multicentre study of fetal cardiac time intervals using magnetocardiography. BJOG (2002) 1.14
Purification and identification of Haemophilus ducreyi cytotoxin by use of a neutralizing monoclonal antibody. Infect Immun (1997) 1.14
Chlorpromazine reduces fluid-loss in cholera. Lancet (1979) 1.12
Learning with computerized guidelines in general practice?: A randomized controlled trial. Fam Pract (2004) 1.11
Interaction of cholera toxin and toxin derivatives with lymphocytes. II. Modulating effects of cholera toxin on in vivo humoral and cellular immune responses. Int Arch Allergy Appl Immunol (1976) 1.10
Influence of paced maternal breathing on fetal-maternal heart rate coordination. Proc Natl Acad Sci U S A (2009) 1.09
Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun (1994) 1.08
Endovascular therapy of brain AVMs prior to radiosurgery. Neurol Res (1998) 1.06
[Comparison of different stool tests for the detection of cancer of the colon]. Dtsch Med Wochenschr (2005) 1.06
The effect of graded immersion on heart volume, central venous pressure, pulmonary blood distribution, and heart rate in man. Pflugers Arch (1978) 1.06
Chlorpromazine inhibits cholera toxin-induced intestinal hypersecretion. Med Biol (1977) 1.04
Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer--results of the analysis of 670 patients with 11 years of follow-up. Eur J Cancer (2002) 1.03
[What is a confidence interval?]. Dtsch Med Wochenschr (2007) 1.01
Molecular cloning and expression of a pituitary gland protein modulating intestinal fluid secretion. J Biol Chem (1995) 1.01
Temporal asymmetries of short-term heart period variability are linked to autonomic regulation. Am J Physiol Regul Integr Comp Physiol (2008) 0.99
Protection against experimental cholera in the rat. A study on the formation of antibodies against cholera toxin and desensitization of adenylate cyclase after immunization with cholera toxin. Int Arch Allergy Appl Immunol (1984) 0.98
The antisecretory factors: inducible proteins which modulate secretion in the small intestine. Comp Biochem Physiol A Comp Physiol (1988) 0.96
Strange baryon resonance production in sqrt s NN=200 GeV p+p and Au+Au collisions. Phys Rev Lett (2006) 0.96
Chlorpromazine reverses diarrhea in piglets caused by enterotoxigenic Escherichia coli. Infect Immun (1979) 0.96
Global transcription and metabolic flux analysis of Escherichia coli in glucose-limited fed-batch cultivations. Appl Environ Microbiol (2008) 0.95
Extrapyramidal motor signs in degenerative ataxias. Arch Neurol (2000) 0.94
[Survival analysis: Cox regression]. Dtsch Med Wochenschr (2007) 0.93
Transverse-momentum and collision-energy dependence of high-pT hadron suppression in Au+Au collisions at ultrarelativistic energies. Phys Rev Lett (2003) 0.93
Antitoxic cholera immunity in mice: influence of antigen deposition on antitoxin-containing cells and protective immunity in different parts of the intestine. Infect Immun (1980) 0.92
Evidence from d+Au measurements for final-state suppression of high-p(T) hadrons in Au+Au collisions at RHIC. Phys Rev Lett (2003) 0.92
Effects of the antisecretory factor in pigs. Pflugers Arch (1987) 0.92
Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Intern Med (1998) 0.92
An enzyme-linked-immunosorbent assay method for detection of immunoglobulins to pertussis toxin. Acta Pathol Microbiol Immunol Scand C (1986) 0.91
Gamma heavy chain disease. Reports of three patients. Acta Med Scand (1972) 0.90
Bile and milk from cholera toxin treated rats contain a hormone-like factor which inhibits diarrhea induced by the toxin. Int Arch Allergy Appl Immunol (1986) 0.90
[The kappa coefficient]. Dtsch Med Wochenschr (2007) 0.89
Intestinal immune response to cholera toxin: dependence on route and dosage of antigen for priming and boosting. Infect Immun (1980) 0.88
Studies on the conjugation of horseradish peroxidase to immunoglobulin G via glutaraldehyde. Med Biol (1979) 0.87
Heart volume in relation to body posture and immersion in a thermo-neutral bath. A roentgenometric study. Pflugers Arch (1974) 0.87
Diffusion-in-gel enzyme-linked immunosorbent assay (DIG-ELISA): optimal conditions for quantitation of antibodies. J Immunol Methods (1980) 0.87
[Comparing methods of measurement]. Dtsch Med Wochenschr (2007) 0.87
[Magnetocardiography for assessment of fetal heart actions]. Geburtshilfe Frauenheilkd (1995) 0.86
Influence of brain tumors on the MR spectra of healthy brain tissue. Magn Reson Med (2011) 0.86
Induction of anti-secretory factor in mice by the nonintestinal parasite Schistosoma mansoni. J Parasitol (1992) 0.86
Chemical modification of cholera toxin for characterization of antigenic, receptor-binding and toxic sites. FEBS Lett (1974) 0.86
Internalization in vivo of cholera toxin in the small intestinal epithelium of the rat. Acta Pathol Microbiol Immunol Scand A (1984) 0.86
Purification and characterization of the antisecretory factor: a protein in the central nervous system and in the gut which inhibits intestinal hypersecretion induced by cholera toxin. Biochim Biophys Acta (1986) 0.86
Intake of monosaccharides or amino acids induces pituitary gland synthesis of proteins regulating intestinal fluid transport. Biochim Biophys Acta (1987) 0.86
Ontogeny of humoral immune parameters in fish. Fish Shellfish Immunol (2005) 0.86
Cloning, recombinant expression and biochemical characterisation of novel esterases from Bacillus sp. associated with the marine sponge Aplysina aerophoba. Appl Microbiol Biotechnol (2004) 0.85
What do serum antibodies to Yersinia enterocolitica indicate? Rev Infect Dis (1985) 0.84
The antisecretory factor: synthesis and intracellular localisation in porcine tissues. Cell Tissue Res (1999) 0.84
Identification of an active site in the antisecretory factor protein. Biochim Biophys Acta (1997) 0.84
Food induced stimulation of the antisecretory factor can improve symptoms in human inflammatory bowel disease: a study of a concept. Gut (2000) 0.84
The interaction between the adenylate cyclase system and insulin-stimulated glucose transport. Evidence for the importance of both cyclic-AMP-dependent and -independent mechanisms. Biochem J (1987) 0.84
[Quality of life in skin diseases: methodological and practical comparison of different quality of life questionnaires in psoriasis and atopic dermatitis]. Hautarzt (1999) 0.84
[Physicians, internet and new knowledge. Utilization and efficiency of new continuing education media in the hospital]. Med Klin (Munich) (2001) 0.83
Time course of cardiac distension with rapid immersion in a thermo-neutral bath. Pflugers Arch (1978) 0.83